'Preliminary studies suggest that this virus exhibits decreased susceptibility to neutralizing antibodies from several people with a history of infection.'
In the thread I linked there should be the exact figures. Vaccines target the whole spike protein (most of them, at least) so it's likely not going to be a problem. It may be for monoclonal antibodies.